Evidence map›Paper›PMID 35841045›Full record

ArticleJournal of translational medicine2022

Correction to: Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway.

Åslaug Helland, Hege G Russnes, Gro Live Fagereng, Khalid Al-Shibli, Yvonne Andersson, Thomas Berg, Line Bjørge, Egil Blix, Bodil Bjerkehagen, Sigmund Brabrand and 43 more

Abstract readPublished Erratum
In one paragraph

Article in Journal of translational medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

53 authors.

Åslaug HellandInstitute for Cancer Research/Department of Oncology/Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway. aslaug.helland@medisin.uio.no.ORCID http://orcid.org/0000-0002-5520-0275
Hege G RussnesInstitute for Cancer Research/Department of Oncology/Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway.
Gro Live FagerengInstitute for Cancer Research/Department of Oncology/Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway.
Khalid Al-ShibliDept. of Pathology, Nordland Hospital, Bodø, Norway.
Yvonne AnderssonHospital Pharmacies Enterprise, Oslo, Norway.
Thomas BergDepartment of Pathology, University Hospital in North of Norway, Tromsø, Norway.
Line BjørgeHaukeland University Hospital, Bergen, Norway.
Egil BlixDepartment of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway.
Bodil BjerkehagenInstitute of Clinical Medicine, University of Oslo, Oslo, Norway.
Sigmund BrabrandInstitute for Cancer Research/Department of Oncology/Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway.
Marte Grønlie CameronHospital of Southern Norway, Kristiansand, Norway.
Astrid DalhaugDepartment of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway.
Dalia DietzelTelemark Hospital Trust, Skien, Norway.
Tom DønnemDepartment of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway.
Espen EnerlyDepartment of Research, The Cancer Registry of Norway, Oslo, Norway.
Åsmund FlobakDepartment of Oncology, The Cancer Clinic, St Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.
Sverre FlugeHelse Fonna, Haugesund, Norway.
Bjørnar GiljeStavanger University Hospital, Stavanger, Norway.
Bjørn Tore GjertsenHaukeland University Hospital, Bergen, Norway.
Bjørn Henning GrønbergDepartment of Oncology, The Cancer Clinic, St Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.
Kari GrønåsPatient Representative, Oslo University Hospital, Oslo, Norway.
Tormod GurenInstitute for Cancer Research/Department of Oncology/Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway.
Hanne HamreAkershus University Hospital, Lørenskog, Norway.
Åse HaugHaukeland University Hospital, Bergen, Norway.
Daniel HeinrichInnlandet Hospital Trust, Lillehammer, Norway.
Geir Olav HjortlandInstitute for Cancer Research/Department of Oncology/Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway.
Eivind HovigInstitute for Cancer Research/Department of Oncology/Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway.
Randi HovlandHead of Section for Cancergenomics Section for Cancer Genomics, Haukeland University Hospital, Bergen, Norway.
Ann-Charlotte IversenPatient Representative, Oslo University Hospital, Oslo, Norway.
Emiel JanssenSection for Cancergenomics, Department of Pathology, Stavanger University Hospital, Stavanger, Norway.
Jon Amund KyteInstitute for Cancer Research/Department of Oncology/Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway.
Hedda von der Lippe GythfeldtInnlandet Hospital Trust, Lillehammer, Norway.
Ragnhild LotheInstitute for Cancer Research/Department of Oncology/Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway.
Jo-Åsmund LundDept of Oncology, Helse Møre and Romsdal Health Trust, Ålesund, Norway.
Leonardo Meza-ZepedaInstitute for Cancer Research/Department of Oncology/Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway.
Monica Cheng Munthe-KaasDepartment of Pediatric Medicine, Oslo University Hospital, Oslo, Norway.
Olav Toai Duc NguyenNorthern Trøndelag Trust, Levanger, Norway.
Pitt NiehusmannDepartment of Pathology, Oslo University Hospital, Oslo, Norway.
Hilde NilsenInstitute of Clinical Medicine, University of Oslo, Oslo, Norway.
Katarina PucoInstitute for Cancer Research/Department of Oncology/Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway.
Anne Hansen ReeInstitute of Clinical Medicine, University of Oslo, Oslo, Norway.
Tonje Bøyum RisteDept of Pathology, Førde Hospital Trust, Førde, Norway.
Karin SembDepartment of Oncology, Vestfold Hospital Trust, Tønsberg, Norway.
Eli Sihn Samdal SteinskogHaukeland University Hospital, Bergen, Norway.
Andreas StensvoldDepartment of Oncology, Kalnes Hospital, Grålum, Norway.
Pål SuhrkeDepartment of Pathology, Vestfold Hospital Trust, Tønsberg, Norway.
Øyvind TennøeDepartment of Oncology, Kalnes Hospital, Grålum, Norway.
Geir E TjønnfjordDepartment of Haematology, Oslo University Hospital, Tønsberg, Norway.
Liv Jorunn VassbotnDept of Oncology, Førde Hospital Trust, Førde, Norway.
Eline AasInstitute of Health and Society, Department of Health Management and Health Economics, University of Oslo, Oslo, Norway.
Kristine AasebøHaukeland University Hospital, Bergen, Norway.
Kjetil TaskenInstitute for Cancer Research/Department of Oncology/Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway.
Sigbjørn SmelandInstitute for Cancer Research/Department of Oncology/Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35841045
PMCPMC9284821

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.